Most Canadians have acquired antibodies against SARS-CoV-2
A study funded and led by the CITF, published in CMAJ, found that as of March 2023, over 75% of people in Canada had antibodies due to a SARS-CoV-2 infection.
CITF-funded findings on pan-Canadian serosurveillance
The latest CITF-funded report from Canadian Blood Services suggests that the 80% mark in estimated infection-acquired seroprevalence among Canadian adults has now been reached.
Intimate partner violence was highly prevalent among gay, bisexual, and other men who have sex with men
An ongoing cohort study that received funding from the CITF for a sub-study has found that many gay, bisexual, and other men who have sex with men (GBM) had experienced or had perpetrated intimate partner violence (IPV) in their lifetime.
Adults of all ages mount robust T-cell responses to COVID-19 vaccination, which are further boosted by breakthrough infection
A CITF-funded study, published in preprint and not yet peer-reviewed, found that adults, including older adults (65-93 years), mount robust T-cell responses to two- and three-dose COVID-19 mRNA vaccination.
Seroprevalence due to infection among Canadian blood donors reached the 80% mark in June
The latest CITF-funded report from Canadian Blood Services suggests that the 80% mark in estimated infection-acquired seroprevalence among Canadian adults has now been reached.
Natural language processing tool improves efficiency in systematic review
A CITF-funded study, published in Research Synthesis Methods, found that implementing a natural language processing (NLP) tool for abstract screening in a living systematic review of SARS-CoV-2 prevalence was feasible and beneficial in a real-world context.
COVID-19 vaccines were equally effective in British Columbia and Ontario among patients receiving kidney dialysis
A CITF-funded study, published in Canadian Journal of Kidney Health and Disease, found that COVID-19 vaccines were highly effective in preventing infection and severe outcomes among patients on maintenance dialysis in both British Columbia and Ontario.
People living with HIV had more than two times the risk of COVID-19 hospitalization compared to HIV-negative individuals
A CITF-funded study, published in the International Journal of Infectious Diseases, found that people living with HIV (PLWH) had more than two times the risk of being hospitalized with COVID-19 as did HIV-negative individuals.
Third COVID-19 vaccine dose during pregnancy does not pose any significant risk to pregnant individuals or their newborns
A CITF-funded study, published in BMJ Medicine, reported that pregnant individuals who received a third COVID-19 vaccine dose (first booster dose) during pregnancy had no increased risk of adverse pregnancy, fetal, and neonatal outcomes compared to those who did not receive a third dose. This study was led by Dr. Deshayne Fell (University of Ottawa and CHEO Research Institute).